MedTrace Logo

Serum Caspase 3, Annexin a2 and Soluble Fas Levels and Endometriosis

NCT03020108 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2017-08-28

No results posted yet for this study

Summary

The study population will comprise of 90 women age varying between 15-55 years, those are candidate for laparoscopic surgery due to definition of \>4 cm endometrioma or any other benign ovarian cysts such as mature teratoma or simple serous cysts on ultrasound examination, chronic pelvic pain, infertility. The blood samples will be drawn for analysis of serum biomarkers.

Conditions

  • Endometriosis
  • Apoptotic Pathway Deregulation

Interventions

OTHER

Blood sample

2 cc blood samples will be drawn from antecubital vein

Sponsors & Collaborators

  • Bakirkoy Dr. Sadi Konuk Research and Training Hospital

    lead OTHER_GOV

Principal Investigators

  • Cihan Kaya, M.D. · Bakırkoy Dr. Sadi Konuk Training and Research Hospital

Eligibility

Min Age
15 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-06-30
Completion
2017-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03020108 on ClinicalTrials.gov